ArticleOne health (Amsterdam, Netherlands)2021
A tool for rapid assessment of wildlife markets in the Asia-Pacific Region for risk of future zoonotic disease outbreaks.
Article in One health (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Advancing green recovery: Integrating one health in sustainable wildlife management in the Asia-Pacific Indigenous People and Local Communities.One health (Amsterdam, Netherlands) · 2025Review
- Wildlife Pathogens and Zoonotic Disease Risk Assessment in Vietnam: A Wildlife Trade Hotspot.Transboundary and emerging diseases · 2025Review
- Mapping hazards to the global food system.Environmental monitoring and assessment · 2024Article
- Article
- Examining the international bushmeat traffic in Belgium: A threat to conservation and public health.One health (Amsterdam, Netherlands) · 2023Article
- Range area and the fast-slow continuum of life history traits predict pathogen richness in wild mammals.Scientific reports · 2023Article
- Investigating Infectious Organisms of Public Health Concern Associated with Wild Meat.Transboundary and emerging diseases · 2023Review
- COVID-19 impacts, opportunities and challenges for wildlife farms in Binh Duong and Ba Ria Vung Tau, Vietnam.Global ecology and conservation · 2022Article
- Wildmeat consumption and zoonotic spillover: contextualising disease emergence and policy responses.The Lancet. Planetary health · 2022Review
- Evaluating wildlife markets for pandemic disease risk.The Lancet. Planetary health · 2021Article
- Addressing Inequalities Toward Inclusive Governance for Achieving One Health: A Rapid Review.Frontiers in public health · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Decades of warnings that the trade and consumption of wildlife could result in serious zoonotic pandemics have gone largely unheeded. Now the world is ravaged by COVID-19, with tremendous loss of life, economic and societal disruption, and dire predictions of more destructive and frequent pandemics. There are now calls to tightly regulate and even enact complete wildlife trade bans, while others call for more nuanced approaches since many rural communities rely on wildlife for sustenance. Given pressures from political and societal drivers and resource limitations to enforcing bans, increased regulation is a more likely outcome rather than broad bans. But imposition of tight regulations will require monitoring and assessing trade situations for zoonotic risks. We present a tool for relevant stakeholders, including government authorities in the public health and wildlife sectors, to assess wildlife trade situations for risks of potentially serious zoonoses in order to inform policies to tightly regulate and control the trade, much of which is illegal in most countries. The tool is based on available knowledge of different wildlife taxa traded in the Asia-Pacific Region and known to carry highly virulent and transmissible viruses combined with relative risks associated with different broad categories of market types and trade chains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.